On 7 June 2021, aducanumab was granted accelerated approval for the treatment of
Alzheimer disease (AD) by the FDA on the basis of amyloid-lowering effects considered …

The global ubiquity of overuse and underuse of health-care resources and the gravity of
resulting harms necessitate an investigation of drivers to inform potential solutions. We …

Advanced AI models hold the promise of tremendous benefits for humanity, but society
needs to proactively manage the accompanying risks. In this paper, we focus on what we …

In nascent industries―whose new technologies are often poorly understood by regulators―
contending with regulatory uncertainty can be crucial to organizational survival and growth …

Abstract Research Summary We explore the challenges that digital platform‐based sharing
economy ventures confront in establishing legitimacy for their business models by …

The financial sector has seen a transformation towards 'sustainable'finance particularly in
Europe, driven also by unprecedented regulatory reforms. At the same time, many are …

Regulation is typically conceived as a two-party relationship between a rule-maker or
regulator (R) and a rule-taker or target (T). We set out an agenda for the study of regulation …

Modern-day markets do not arise spontaneously or evolve naturally. Rather they are crafted
by individuals, firms, and most of all, by governments. Thus" marketcraft" represents a core …

Written by B. Guy Peters, a leading authority in the field, this comprehensive exploration of
the political and policy making roles of public bureaucracies is now available in a fully …

What do public administrators and policy analysts have in common? Their work is
undertaken within networks formed when different organizations align to accomplish some …